姓名：翟振国 性别：男 职称：主任医师、副教授 招生院所：中日友好医院 招生类型：专业学位(硕) 招生专业：内科学（呼吸系病）(硕) 研究方向名称：呼吸病学，肺栓塞与肺血管病 电子信箱：zhaizhenguo2011@126.com


社会任职
1. 中华医学会呼吸病学分会青年委员会委员
2. 国际肺血管病研究院(PVRI)委员兼秘书
3. 国际肺血管病研究院(PVRI)中国中心秘书
4. 美国胸科医师学院资深委员
5. Clinical Respiratory Journal 副主编
6. Thrombosis and Haemostasis审稿专家
7. Chinese Medical Journal审稿专家
8. Journal of Thrombosis and Thrombolysis 特约审稿
9. 中国医师协会重症医学医师分会 心脏重症专家委员会委员
10. 中华医学杂志 通讯编委
11. 海峡两岸医药卫生交流协会呼吸病学专业委员会常务委员
12. 中国呼吸医学教育学院 学术委员会常务委员、肺血管疾病分委会主任
13. 中华老年心血管病杂志编委
14. 北京医学会呼吸病学分会肺血管学组委员
15. 中华医学会呼吸病学分会肺栓塞与肺血管病学组副组长
16. 中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会主任委员
个人简历
1. 200109-200407:首都医科大学 医学博士
2. 200503-200506:美国加州大学圣地亚哥医学分校 访问
3. 200710-201311:首都医科大学附属北京朝阳医院-北京呼吸疾病研究所 副主任医师
4. 200810-201004:英国帝国理工大学汉姆史密斯医院 访问,临床研究
5. 201110-201305:首都医科大学附属北京朝阳医院 副教授
6. 201311-201506:首都医科大学附属北京朝阳医院 主任医师
7. 201506-:中日友好医院 副主任/主任医师
重要学术论文
1. Zhang M#, Zhang YX#, Zhang Z, Wang J, Shao X, Xie WM, Wan J, Zhai ZG*, Wang C*..Awareness and management of pulmonary embolism among physicians in China: a nationwide cross-sectional study.. Journal of Thrombosis and Thrombolysis. 2019,47(3):436-443.SCI
2. Zhai Z#, Kan Q, Li W, Qin X, Qu J, Shi Y, Xu R, Xu Y, Zhang Z#, Wang C*, DissolVE-2 investigators..VTE Risk Profiles and Prophylaxis in Medical and Surgical Inpatients: The Identification of Chinese Hospitalized Patients' Risk Profile for Venous Thromboembolism (DissolVE-2)-A Cross-sectional Study. Chest. 2019,155(1):144-122.SCI
3. Zhang Z#, Lei J#, Zhai Z*, Yang Y, Wan J, Xie W, Wang C*..Comparison of prediction value of four bleeding risk scores for pulmonary embolism with anticoagulation: a real-world study in Chinese patients. Clin Respir J. 2019,13（3）:139-147.SCI
4. Zhang Z, Lei J, Shao X, Dong F, Wang J, Wang D, Wu S, Xie W, Wan J, Chen H, Ji Y, Yi Q, Xu X, Yang Y, Zhai Z*, Wang C*, China Venous Thromboembolism Study Group,.Trends in Hospitalization and In-Hospital Mortality from Venous Thromboembolism, 2007 to 2016, in China.,. Chest. 2019,155(2):342-353.SCI
5. Zou L, Li W, Han J, Yang Y, Jin J, Xiao F, Xu X, Zhai Z*,.Identification of a low frequency missense mutation in MUC6 contributing to pulmonary artery hypertension by whole-exome sequencing. Pulmonary Circulation,. 2018,8(3):1-8.SCI
6. Zhang Y, Li J, Yang Y, Huang K, Miao R, Zhai Z*, Wang C*..Identification of haptoglobin as a potential diagnostic biomarker of acute pulmonary embolism.. Blood Coagulation and Fibrinolysis. 2018,29(3):275-281.SCI
7. Zou L , Zhang J ,Han J, Li W, Su F, Xu X, Zhai Z*,Xiao F*.cGMP interacts with tropomyosin and downregulates actin-tropomyosin-myosin complex interaction.. Respiratory Research. 2018,19(1):201.SCI
8. Chen X, Zhai Z*, Huang K, Xie W, Wan J, Wang C..Bosentan Therapy for Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: A Systemic Review and Meta-Analysis. Clin Respir J. 2018,12（6）:2065-2074.SCI
9. 朱妍妍,邝土光*,翟振国*,杨媛华,谢万木.不同强度华法林抗凝治疗对肺血栓栓塞症二级预防预后及凝血功能的影响研究. 中国实用内科杂志. 2017,37(12):1099-1101.
10. 门剑龙,翟振国*.血栓实验室检查的循证发展与挑战. 中华检验医学杂志. 2017,40(4):331-334.核心期刊
11. Zhang Z, Zhai Z*, Yang Y, Wan J, Xie W, Zhu J, Shen YH, Wang C..Diabetes mellitus is associated with increased bleeding in pulmonary embolism receiving conventional anticoagulant therapy: findings from a“real-world” study.. Journal of Thrombosis and Thrombolysis. 2017,43(4):540-549.SCI
12. Zhai Z#, Zhou X#, Zhang S#, Xie W, Wan J, Kuang T, Yang Y, Huang H, Wang C*..The impact and financial burden of pulmonary arterial hypertension on patients and caregivers: results from a national survey.. Medicine. 2017,96(39):e8165.SCI
13. 周霞,石慧,马瑞晓,翟振国*.动脉性肺动脉高压和慢性血栓栓塞性肺动脉高压患者生活质量及其影响因素研究进展. 中国实用内科杂志. 2017,37(08):754-756..
14. 翟振国,王丁一,王辰*.全面推进肺血栓栓塞症的精准医学研究. 中华医学杂志. 2017,(36):2803-2805.核心期刊
15. 翟振国,王辰*.重视肺动脉高压的多学科甄别与综合处理. 中华医学杂志. 2016,96(16):1233-1235.核心期刊
16. Zhou X, Zhang Z, Zhai Z*, Zhang Y, Miao R, Yang Y, Xie W, Wan J, Wang C..Pleural effusions as a predictive parameter for poor prognosis for patients with . Journal of Thrombosis and Thrombolysis. 2016,42(3）:432-40.SCI
17. 翟振国*,陈新旺,王辰.ESC／ERS《肺动脉高压诊断和治疗指南》制定过程中的方法学及主要变化. 中华医学杂志. 2016,96(4):-.核心期刊
18. Zhang S#, Zhai Z#, Yang Y#, Zhu J, Kuang T, Xie W, Yang S, Liu F, Gong J, Shen YH, Wang C*..Pulmonary embolism risk stratification by European Society of Cardiology is associated with recurrent venous thromboembolism: Findings from along-term follow-up study.. International Journal of Cardiology. 2016,202:275-81.SCI
19. Wang C#*, Zhai Z#, Yang Y#, Cheng Z, Ying K, Liang L, Dai H, Huang K, Lu W, Zhang Z, Cheng X, Shen YH. .Inverse relationship of bleeding risk with clot burden during pulmonary embolism treatment with LMW heparin. Clin Respir J. 2016,10（5）:596-605.SCI
20. Li Y#, Wang Y#, Zhai Z#, Guo X, Wu Y, Yang Y, Lu X*.Relationship between echocardiographic and cardiac magnetic resonance imaging-derived measures of CTEPH. Thrombosis Research. 2015,135(4):602-6.SCI
21. Zhang S#, Zhai Z#*, Yang Y#, Zhu J, Gong J, Xie W, Kuang T, Wang C*. .Long-term treatment with low-molecular-weight heparin prolonged the survival time for acute pulmonary embolism patients concurrent with malignancy: An observational analysis from a long-term follow-up study. Thrombosis Research. 2015,135:582–587.SCI
22. Zhang Z, Zhai ZG*, Liang LR, Liu FF, Yang YH, Wang C. .Lower dosage of recombinant tissue-type plasminogen activator (rt-PA) in the treatment of acute pulmonary embolism: A systematic review and meta-analysis. Thrombosis Research. 2014,133(23):357–363.SCI
23. 谢万木,翟振国*.慢性血栓栓塞性肺动脉高压研究中应关注的几个问题. 中华医学杂志. 2014,(22):-.核心期刊
24. Li Y, Zhai Z#, Wu Y, Yang Y, Gu S, Liu Y, Su P, Wang C.Improvement of right ventricular dysfunction after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension. Thrombosis Research. 2013,131（5）:196-201.SCI
25. Li YY, Zhai ZG*, Yang YH, Pang BS, Wang HY, Zhang W, Zhao L, Wang J, Wang C*..Association of the 894G>T polymorphism in the endothelial nitric oxide synthase. Thromb Res. . 2011,127(4:324-327.SCI
26. Zhai Z, Murphy K, Tighe H, Wang C, Wilkins MR, Gibbs JS, Howard LS*.Differences in ventilatory inefficiency between pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Chest. 2011,140(5):1284-1291.SCI
27. Yang Y, Liang L, Zhai Z, He H, Xie W, Peng X, Wang C*; on behalf of investigators for the National Cooperative Project for the Prevention and Treatment of PTE-DVT. .Pulmonary Embolism Incidence and Fatality Trends in Chinese Hospitals from 1997 to 2008: A Multicenter Registration Study. PLoS One. 2011,6（11）:e26861.SCI
28. Zhai Z, Wang J, Zhao L, Yuan XJ, Wang C*.Pulmonary hypertension in China：Pulmonary Vascular Disease: The Global Perspective. Chest. 2010,137:69S-77S.SCI
29. Zhai Z, Zhan X, Yang Y, Wang C*..Recent research on venous thromboembolism in China: a brief report from China Venous Thromboembolism Study Group. Chinese Medical Journal. 2010,123(4):485-490.SCI
30. Wang C#*, Zhai Z#, Yang Y#, Wu Q, Cheng Z, Liang L, Dai H, Huang K, Lu W, Zhang Z, Cheng X, Shen YH; China Venous Thromboembolism (VTE) Study Group..Efficacy and Safety of Low Dose Recombinant Tissue-Type Plasminogen Activator for the Treatment of Acute . Chest. 2010,137(2):254-262.SCI
31. Wang C#*, Zhai Z#, Yang Y#, Yuan Y, Cheng Z, Liang L, Dai H, Huang K, Lu W, Zhang Z, Cheng X, Shen YH; China Venous Thromboembolism Study Group..Efficacy and safety of 2-hour urokinase regime in acute pulmonary embolism: a randomized controlled trial. Respiratory Research. 2009,128:1-9.SCI
32. 翟振国，杨媛华，王辰*.重组组织型纤溶酶原激活剂50 mg/2 h方案用于国人急性肺血栓栓塞症治疗可获更好风险效益比. 中华医学杂志. 2009,89（38）:24.核心期刊
主编或副主编的著作/译著
1. 《肺栓塞临床实战》,主编,人民卫生出版社,201608
2. 《肺动脉高压》,副主编,人民卫生出版社,201409
重要奖项
1. “有突出贡献中青年专家”荣誉称号 201909
2. 第十四届中国医师协会呼吸医师分会“优秀呼吸医师”称号 201906
3. 推动行业前行的力量 十大医学新锐 201701
4. 国人肺血栓栓塞症的规范化诊断与治疗研究 中华医学科技奖 二等奖 200812
5. 提高我国肺血栓栓塞症诊疗水平的系列研究 国家科学技术进步 二等奖 200812